The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nitisinone Dipharma 20 mg hard capsules

Dipharma Arzneimittel GmbHPA23449/001/004

Main Information

Trade NameNitisinone Dipharma 20 mg hard capsules
Active SubstancesNitisinone
Dosage FormCapsule, hard
Licence HolderDipharma Arzneimittel GmbH
Licence NumberPA23449/001/004

Group Information

ATC CodeA16AX04 nitisinone


License statusAuthorised
Licence Issued01/05/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back